{"schema_version":"secwatch.filing_event.v1","accession":"0001425450-26-000032","form_type":"8-K","ticker":"KIDS","cik":"0001425450","company_name":"ORTHOPEDIATRICS CORP","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.269446+00:00","generated_at":"2026-05-15T00:37:13.728046+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OrthoPediatrics Q1 revenue up 13% to $59.4M; lifts FY2026 guidance to $263-267M","bullets":["Revenue $59.4M (13% YoY); US +11%, International +22%; Trauma & Deformity +14%, Scoliosis +13%.","Adjusted EBITDA of $2.2M vs. -$0.4M in Q1 2025; net loss unchanged at $10.7M (-$0.45 EPS).","Free cash flow usage improved 40% to -$5.0M from -$8.4M.","FY2026 revenue guidance raised to $263-267M (prior $262-266M); adj. EBITDA reiterated ~$25M.","Cash & equivalents $50.9M (down from $62.9M at Dec 31, 2025)."],"urls":{"canonical":"https://secwatch.observer/filing/0001425450-26-000032","json":"https://secwatch.observer/filing/0001425450-26-000032.json","markdown":"https://secwatch.observer/filing/0001425450-26-000032.md","text":"https://secwatch.observer/filing/0001425450-26-000032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000032/0001425450-26-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000032/kids-20260430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:37:13.728046+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"754e8e2d73757181c00c637ab4eae0eb108f287a","claim":"ORTHOPEDIATRICS CORP reported the first quarter ended March 31, 2026 results: revenue $59.4 million, net income Net loss for the first quarter of 2026 was $10.7 million, EPS $0.45 per basic and diluted share. Guidance raised.","evidence_excerpt":"quarter ended March 31, 2026. First Quarter 2026 and Business Highlights • Helped a record of over 45,000 children in the first quarter of 2026 • Generated total revenue of $59.4 million for the first quarter of 2026, up 13% from $52.4 million in the first quarter of 2025; domestic revenue increased 11% and international revenue increased 22% in the quarter •","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000032/0001425450-26-000032-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2026"},{"label":"Revenue","value":"$59.4 million"},{"label":"Net income","value":"Net loss for the first quarter of 2026 was $10.7 million"},{"label":"EPS","value":"$0.45 per basic and diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}